ArticleFrontiers in immunology2025

Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Wei Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.